Drawing for IMMRAY

USPTO serial 79176421

IMMRAY

Reviewed by CopyMark Law Group

Reg. 5202108Status 404
Filing date
Status date
Registration date
May 16, 2017
Examiner
EISNACH, MICHAEL PATRICK
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IMMRAY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan Neuberger Weller

Susan Neuberger Weller Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C555 12th Street NW, Suite 1100Washington, DC 20004UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Sanitary preparations for medical use; biological indicators for medical diagnosis; diagnostic preparations for medical purposes; diagnostic reagents for medical use; chemical reagents for medical purposes for the diagnosis of cancer and auto-immune diseasesSECTION 70 - CANCELLED—
009Computer software for diagnosis of disease; Computer software for diagnosing of cancer diseases; Computer software for diagnosing of pancreatic cancer; Computer software for diagnosing of breast cancer; Computer software for diagnosing of prostate cancer; Computer software for diagnosing of auto-immune diseases; DNA chipsSECTION 70 - CANCELLED—
010Medical apparatus and instruments for diagnostic, prognostic patient stratification, examination and monitoring purposes, namely, apparatus for multiplex measuring of proteins in blood; diagnostic apparatus for medical purposes for diagnosing cancer and auto-immune diseases; sensor apparatus for medical use in diagnosis for diagnosing cancer and auto-immune diseases; apparatus for carrying-out diagnostic tests for medical purposes for diagnosing cancer and auto-immune diseases; medical diagnostic apparatus for detecting cancer and auto-immune diseases; DNA microarray for use in medical research for medical purposes for the diagnosis of cancer and auto-immune diseases; blood testing analyzers for medical purposes for the diagnosis of cancer and auto-immune diseasesSECTION 70 - CANCELLED—
042Medical research services; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes in the area of pancreatic cancerous diseases; scientific research for medical purposes in the area of breast cancerous diseases; scientific research for medical purposes in the area of prostate cancerous diseases; scientific research for medical purposes in the area of auto-immune diseases; providing computer aided medical testing services, namely, computer aided blood analysis services in the field of cancer and auto-immune diseases research; research and development of computer softwareSECTION 70 - CANCELLED—
044Performing diagnosis of diseases; medical services for the diagnosis of conditions of the human body; performing diagnosis of cancer and auto-immune diseasesSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 19, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Mar 19, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 7, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 4, 2024NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jan 4, 202471AGREGISTERED-SEC.71 ACCEPTED—
Jan 3, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 4, 2023ES71TEAS SECTION 71 RECEIVED—
May 16, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 29, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 17, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 17, 2017FIMPFINAL DISPOSITION PROCESSED—
Aug 16, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 16, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 5, 2017OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 19, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 19, 2017OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 28, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 28, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 24, 2017GPNXNOTIFICATION PROCESSED BY IB—
Feb 8, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 8, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 8, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 24, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 16, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 16, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Jan 16, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 16, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 16, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 19, 2016GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 19, 2016GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 19, 2016CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 28, 2016AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jun 28, 2016PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jun 20, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 20, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 18, 2016ALIEASSIGNED TO LIE—
Jun 10, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 4, 2016RFNTREFUSAL PROCESSED BY IB—
Dec 11, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 10, 2015RFRRREFUSAL PROCESSED BY MPU—
Dec 9, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 8, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2015DOCKASSIGNED TO EXAMINER—
Nov 25, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 21, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 19, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance